Related Experiment Video

Updated: May 5, 2026

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
07:01

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

1.2K

An emerging role of PARK2 in cancer

Liang Xu1, De-chen Lin, Dong Yin

  • 1Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

Journal of Molecular Medicine (Berlin, Germany)
|December 4, 2013
PubMed

Insights

The PARK2 (PARKIN) gene acts as a tumor suppressor, but its dual role in cell survival and growth suppression complicates its function in cancer progression. Further research is needed to understand PARK2's complex role in tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • PARK2 (PARKIN) is an E3 ubiquitin ligase regulating cellular processes.
  • PARK2 dysfunction is linked to parkinsonism and cancer.
  • PARK2 acts as a tumor suppressor, but has dual functions in cell survival and growth.

Purpose of the Study:

  • To summarize genetic lesions of PARK2 in human cancers.
  • To discuss the current understanding of PARK2 in cancer progression.
  • To highlight future research directions for PARK2 in oncology.

Main Methods:

  • Literature review of genetic lesions in human cancers.
  • Analysis of existing biological studies on PARK2 functions.
  • Synthesis of current knowledge on PARK2 and cancer.

Main Results:

  • Frequent inactivation of PARK2 observed in various human cancers.
  • Park2-deficient mice exhibit increased susceptibility to tumorigenesis.
  • PARK2 demonstrates both pro-survival and growth-suppressive functions in biological studies.

Conclusions:

  • PARK2 plays a critical role in tumor suppression.
  • The complex functions of PARK2 in cancer progression require further investigation.
  • Future research should focus on elucidating PARK2's precise role in tumorigenesis and potential therapeutic strategies.

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

9.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K